phone icon  Int'l : +1-503-894-6022
Allied Market Research
0
Shopping Cart is Empty..
$ 0

The global medical automation technologies market provides various automated services in health monitoring, prescriptions, therapeutics etc. The global medical technologies market revenue stood at $300 billion in 2011 and it is expected to grow at a CAGR of 7% by 2016. The medical automation technologies market is expected to have a significant market share as highly automated and sophisticated services are available in the market. Venture capitalists are investing in the market to boost the development of medical automation, which is a key driver for the market. For example, Google started a healthcare company, Calio, and is now developing smart contact lens for monitoring diabetes.

However, companies have to go through stringent approval procedures to launch products or services which is a restraint for the growth of the market. U.S. FDA has been criticized in the past for over regulation and delay in product launches. Another challenge for companies in the market is to overcome the 2.3% excise tax burden on medical devices. Most of the companies are opposed to this tax and are demanding to repeal it.   

Some of the key companies profiled in this report are Acrobot Company Ltd., Awarepoint Corp., Clearcount Medical Solutions, Inc.,Ekahau Inc., Ge Healthcare, eScreen Inc. , iCad INC.,Intuitive Surgical, Inc., Philips Healthcare, Quiqmeds, Inc., t+ Medical Americas and U-Systems, Inc.

KEY BENEFITS

  • This report provides market intelligence with respect to health assessment & monitoring, automated imaging & image analysis, automated prescription formulation and dispensing, automated therapeutic (nonsurgical) procedures, medical robotics and computer-assisted surgical devices, automated laboratory testing and analysis, automated healthcare logistics, resource and personnel tracking and geographies so that companies can make precise investment decisions
  • Deep dive analysis of top factors affecting the market growth and their impact in the short and mid-term
  • Value chain analysis provides significance of the role of all stakeholders of the market
  • Porter’s five forces analysis offers insights into the potency of buyers and suppliers, competitive scenario of the market and the threat of new entrants and substitutes
  • SWOT analysis and strategic developments of key players are included in the report so that companies can understand the competitive landscape and make alterations in their plans to maintain their market share
  • Examine the challenges and opportunities in the medical automation technologies market so that companies can capitalize on the opportunities and increase revenue
  • Estimations are derived from the current market scenario and expected future trends for the period of 2013-2020 with 2012 as base figures
  • Geographic analysis offers in-depth implications of the trends in various regions and companies can make region specific strategies to gain competitive advantages

KEY MARKET SEGMENTS

GLOBAL MARKET, BY AUTOMATED HEALTH ASSESSMENT AND MONITORING

  • Automated home monitoring and telemetry
  • Telehealth kiosks
  • Automated eye examination devices
  • Automated drug testing
  • Wearable monitors
  • Automated drug testing

GLOBAL MARKET, BY AUTOMATED IMAGING AND IMAGE ANALYSIS

  • Automated radiography and fluoroscopy
  • Automated whole-breast ultrasound
  • Computer-aided detection
  • Automated microscopy
  • Automated skin cancer detection
  • Endoscopic capsules
  • Automated microscopy

GLOBAL MARKET, BY AUTOMATED PRESCRIPTION FORMULATION AND DISPENSING

  • Packaging machines
  • Intravenous compounders
  • Dispensing machines

GLOBAL MARKET, BY AUTOMATED THERAPEUTIC (NONSURGICAL) PROCEDURES

  • Automated defibrillators
    • Portable Automated Defibrillators
    • Wearable Defibrillators
    • Implantable Defibrillators
  • Automated medication delivery systems
    • Implantable Drug Pumps
    • Wearable Drug Pumps

GLOBAL MARKET, BY MEDICAL ROBOTICS AND COMPUTER-ASSISTED SURGICAL DEVICES

  • Surgical planners and simulators
  • Surgical navigation systems
    • Imaging Technologies
    • Tracking Technologies
    • Display Technologies
  • Surgical robots
    • Robotically Assisted Micro-manipulation
    • Steady-hand Systems
    • Robotic “Wrists” and Other Dexterity Enhancements
    • Pre-programmed Robots
    • Constraint Robots
    • Voice Control
  • Intelligent operating rooms and related equipment
    • Data Routing
    • User Interface
    • Open System Architectures

GLOBAL MARKET, BY AUTOMATED LABORATORY TESTING AND ANALYSIS

  • Central Laboratory Systems
  • Point-of-care Testing Systems

GLOBAL MARKET, BY AUTOMATED HEALTHCARE LOGISTICS, RESOURCE AND PERSONNEL TRACKING

  • Automated hospital pickup and delivery
    • Pneumatic Tubes
    • Automated Guided Vehicles
  • Hospital asset/patient/staff tracking systems
    • Active RFID
    • Wi-Fi
    • Hybrid Systems
    • Sensor Tags
    • Real-time Location Systems

GLOBAL MARKET, BY GEOGRAPHY

  • North America
  • Europe
  • Asia-Pacific
  • RoW

KEY AUDIENCES

  • Medical automation technology providers
  • Healthcare sector service providers
  • Academic & research institutes
Let us know more about your research need and we will customize an offer exclusively for you!
*
*
*
*
*
*
*
security
*

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
SINGLE USER
GROUP LICENSE
SITE LICENSE
GLOBAL LICENSE
$3792
$4440
$6060
$8724
LICENSE INFO
Users/Sharing
Restricted to one authorized user

Limited to 5 authorized users

Up to 25 users


unlimited within company / enterprise
Copy/Paste
Allowed up to 20% of the content
Allowed up to 25% of the content
Allowed up to 50% of the content
allowed 100%

Printing
One print only

Five Prints

Unlimited for internal use
Unlimited for internal use
Delivery Formats
ADDED BENIFITS
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
connect
Need to add more ?
request

Single User $4740
$3792
Group User $5550
$4440
Site User $7575
$6060
Global User $10905
$8724
buy now

Discount will be applied in cart.
First time buyer ?
Check offers and discount
on this report
REQUEST QUOTE
Need More Information
phone_n +1-503-894-6022

Help AMR help@alliedmarketresearch.com
Or
Send Enquiry
WHY ALLIED MARKET RESEARCH?
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
RECENTLY VIEWED REPORTS
get_n
SIMILAR MARKET REPORTS
  • ...
    The male infertility market is expected to grow to $301.5 million by 2020 with a CAGR of 4.9% during 2013-2020. Male infertility is defined as the inability of a male to impregnate his female partner after a year of unprotected intercourse. 20% of the total infertility is due to male factors. The major factors driving the male infertility market are the change in lifestyle, increasing age, environmental effects, etc., and these factors are majorly contributing to the rise in male infertility levels. The major limitation experienced in the male infertility market is due to repeated treatment failures leading to an emotional impact on the patient.
    Apr 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Pharmaceutical excipients are inert substances, other than the pharmacologically active drug, which are included in the manufacturing process or are present in the pharmaceutical product dosage form. Excipients are widely used in drug formulation to provide long-term stability, add bulkiness to solid formulations and facilitate drug absorption. They also enhance the overall safety or functionality of the product during storage or use. The world pharmaceutical excipients market size is evaluated to reach 728.4 kilo tons in volume by 2020, accounting for a revenue of $6.4 billion. Besides this, world pharmaceuticals excipients market would reach $6.4 billion by 2020 at a CAGR of 7.6% during 2015 and 2020
    Feb 2016 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    COPD and Asthma devices, namely inhalers and nebulizers turn out to be the most dynamic solution for the treatment of the patients suffering from chronic obstructive pulmonary disease and asthma. The global COPD and Asthma devices market was valued at $25,366.5 million in 2013 and is expected to grow at the CAGR of 4.5% during the forecast period 2014-2020.
    Nov 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Enteral feeding devices are used to deliver nutrition or medications directly into the stomach or intestine. These devices are commonly used to feed the specialized diet in elderly or bedridden patients suffering from chronic ailments such as neurological disorders, cancer, gastro intestinal and inherited metabolic diseases.
    Aug 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
ON DEMAND REPORTS
  • ...
    Atrial fibrillation (AF) is a type of arrhythmia which is characterized by poor blood flow in the body due to an irregular and rapid heart rate. The geriatric population is generally more susceptible to this disease. Promising results in clinical trials for combination treatment for atrial fibrillation boosts the growth of the global atrial fibrillation market.
    Aug 2016 | View Details >>
  • ...
    Safety syringes consist of an inbuilt safety mechanism and either a detachable or permanently attached needle. They help protect healthcare workers from accidental needlestick injuries. Several countries have introduced legislation, which ensures the compulsory use of safety syringes to decrease needle stick injuries and prevent needle re-use. Introduction of this legislation has led to safety syringes being more commonly used than conventional syringes, which in turn has led to considerable growth in the safety syringe market.
    Aug 2016 | View Details >>
  • ...
    The 3D cell culture is an environment in which biological cells are grown or allowed to interact with its surroundings in all three dimensions. The ability of 3D culture to reconstruct the anatomy or physiology of a tissue for informative or useful study has made it to gain an upper hand over 2D cultures in the market.
    Aug 2016 | View Details >>
  • ...
    Oral Proteins and Peptides are the formulations that are orally administered by the patient. Usually, formulations containing proteins and peptides are administered via intravenous and subcutaneous route due to instability and sensitivity towards body fluids. Oral route of administration is very convenient route; however, the bioavailability of proteins and peptides is less, when administered orally due to degradation of amino acids in gastrointestinal tract. With the advancement in technology formulation containing protein and peptides are introduced in the market that can be orally administered with no change in therapeutic activity and pharmacokinetic aspects.
    Aug 2016 | View Details >>